RO-7 is a second-generation endonuclease inhibitor targeting the PA subunit of influenza A and B virus polymerases; it exhibits broad-spectrum anti-influenza activity in vitro and protects mice from lethal challenge with both influenza A and B viruses; it is a potent inhibitor of influenza virus replication and belongs to a new class of drugs in late-stage clinical trials for the treatment of influenza virus infection.